Reports

435 Results (Page 5 of 18)

Clinical Trials Markets Research Reports

Clinical Trials

Spain Neurology Clinical Trials Market Analysis

The Spain Neurology Clinical Trials market is projected to grow from $100.9 Mn in 2022 to $143.5 Mn by 2030, registering a CAGR of 4.5% during the forecast period of 2022 - 2030. The market will be driven by well-established infrastructure, skilled researchers, and access to a big patient population. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc, Grifols, S.A. & Almirall, S.A.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

South Korea Neurology Clinical Trials Market Analysis

The South Korea Neurology Clinical Trials market is projected to grow from $76.4 Mn in 2022 to $126.5 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022 - 2030. The market will be driven by the supportive regulatory environment and increasing interest from pharmaceutical companies investing in neurology clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Hoffmann-La Roche, Biogen & Chong Kun Dang Pharmaceutical.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

Singapore Neurology Clinical Trials Market Analysis

The Singapore Neurology Clinical Trials market is projected to grow from $6.28 Mn in 2022 to $10.08 Mn by 2030, registering a CAGR of 6.1% during the forecast period of 2022 - 2030. The market will be driven by investments in clinical research and fostering collaborations between researchers, healthcare professionals, and industry partners. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, Biogen & Invitrocue Pte Ltd.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

Saudi Arabia Neurology Clinical Trials Market Analysis

The Saudi Arabia Neurology Clinical Trials market is projected to grow from $88.9 Mn in 2022 to $152.8 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by the high prevalence of neurological disorders, and increasing investment in healthcare infrastructure. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis AG & Tabuk Pharmaceuticals.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

Philippines Neurology Clinical Trials Market Analysis

The Philippines Neurology Clinical Trials market is projected to grow from $11.5 Mn in 2022 to $18.3 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The market will be driven by the country's growing clinical trial industry and a large pool of potential study participants. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Pfizer & Philippine Pharma Solutions, Inc.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

Mexico Neurology Clinical Trials Market Analysis

The Mexico Neurology Clinical Trials market is projected to grow from $78.5 Mn in 2022 to $122.7 Mn by 2030, registering a CAGR of 5.75% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of neurological illnesses and increased investments in R&D by pharmaceutical companies. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis AG & Laboratorios Silanes.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

Global Clinical Trial Patient Recruitment Services Market Analysis

The Global clinical trial patient recruitment services market is projected to grow from $ 0.84 Mn in 2022 to $1.56 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-30. The Global clinical trial patient recruitment services market is a rapidly growing market that provides services to support the recruitment of patients for clinical trials. Some key players in the global clinical trial patient recruitment services market include IQVIA, Parexel International, PRA Health Sciences, Syneos Health, and WCG Clinical. Other important players include ICON plc, Medpace, Charles River Laboratories, and Premier Research.

PUBLISHED: Feb, 2023 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

Japan Neurology Clinical Trials Market Analysis

The Japan Neurology Clinical Trials market is projected to grow from $325.1 Mn in 2022 to $518.1 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The market will be driven by the high prevalence of neurological diseases and a robust healthcare system. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Pfizer, Eisai Co., Ltd & Daiichi Sankyo.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

Italy Neurology Clinical Trials Market Analysis

The Italy Neurology Clinical Trials market is projected to grow from $125.5 Mn in 2022 to $185.5 Mn by 2030, registering a CAGR of 5% during the forecast period of 2022 - 2030. The market will be driven by the rising demand for novel therapies for neurological disorders and the supportive regulatory climate in Italy. The market is segmented by phase, by study design & by indication. Some of the major players include AstraZeneca, Chiesi Farmaceutici & Menarini.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

Indonesia Neurology Clinical Trials Market Analysis

The Indonesia Neurology Clinical Trials market is projected to grow from $31.4 Mn in 2022 to $48.2 Mn by 2030, registering a CAGR of 5.5% during the forecast period of 2022 - 2030. The market will be driven by the rising investments by global pharmaceutical companies in Indonesia due to reduced operating costs and improved healthcare infrastructure. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Roche & PT Dexa Medica.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

Germany Neurology Clinical Trials Market Analysis

The Germany Neurology Clinical Trials market is projected to grow from $191.4 Mn in 2022 to $256 Mn by 2030, registering a CAGR of 3.7% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of neurological illnesses such as Alzheimer's, Parkinson's, multiple sclerosis, and epilepsy and regulatory frameworks that encourage clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Pfizer & Bayer.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

France Neurology Clinical Trials Market Analysis

The France Neurology Clinical Trials market is projected to grow from $279.3 Mn in 2022 to $371.1 Mn by 2030, registering a CAGR of 3.62% during the forecast period of 2022 - 2030. The market will be driven by the growing frequency of neurological diseases and the robust research infrastructure of France. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, Sanofi SA & Neuraxpharm France SAS.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

Egypt Neurology Clinical Trials Market Analysis

The Egypt Neurology Clinical Trials market is projected to grow from $14.6 Mn in 2022 to $25.2 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by the increasing involvement from both global and local companies, a supportive regulatory environment and a growing pool of qualified professionals. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer, Novartis, Minapharm Pharmaceuticals & EIPICO.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

China Neurology Clinical Trials Market Analysis

The China Neurology Clinical Trials market is projected to grow from $420.4 Mn in 2022 to $722.4 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by the country's increasing incidence of neurological disorders and pharmaceutical firms boosting their investments in R&D. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer, Novartis, Shanghai Green Valley Pharmaceuticals & Jiangsu Hengrui Medicine.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

Brazil Neurology Clinical Trials Market Analysis

The Brazil Neurology Clinical Trials market is projected to grow from $130.8 Mn in 2022 to $216.4 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022 - 2030. The market will be driven by the high prevalence of neurological disorders and government initiatives to support clinical research in the country. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Biogen Inc & Aché Laboratórios Farmacêuticos S.A.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

Australia Neurology Clinical Trials Market Analysis

The Australia Neurology Clinical Trials market is projected to grow from $62.8 Mn in 2022 to $107.8 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by internationally competitive government subsidies for R&D investment and a well-developed infrastructure to support clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Biogen Inc, Neuroscience Trials Australia & Prana Biotechnology Limited.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Clinical Trials

Thailand Virtual Clinical Trials Market Analysis

This report presents a strategic analysis of the Thailand Virtual Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Thailand Virtual Clinical Trials Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2023 | PRICE: $3999

Clinical Trials

Thailand Growth Hormone Deficiency Clinical Trials Market Analysis

This report presents a strategic analysis of the Thailand Growth Hormone Deficiency Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Thailand Growth Hormone Deficiency Clinical Trials Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2023 | PRICE: $3999

Clinical Trials

Thailand Clinical Trials Support Service Market Analysis

This report presents a strategic analysis of the Thailand Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Thailand Clinical Trials Support Service Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2023 | PRICE: $3999

Clinical Trials

Turkey COVID-19 Clinical Trials Market Analysis

This report presents a strategic analysis of the Turkey COVID-19 Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Turkey COVID-19 Clinical Trials Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2023 | PRICE: $3999

Clinical Trials

Turkey Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis

This report presents a strategic analysis of the Turkey Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Turkey Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2023 | PRICE: $3999

Clinical Trials

Turkey Growth Hormone Deficiency Clinical Trials Market Analysis

This report presents a strategic analysis of the Turkey Growth Hormone Deficiency Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Turkey Growth Hormone Deficiency Clinical Trials Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2023 | PRICE: $3999

Clinical Trials

Turkey Virtual Clinical Trials Market Analysis

This report presents a strategic analysis of the Turkey Virtual Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Turkey Virtual Clinical Trials Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2023 | PRICE: $3999

Clinical Trials

Turkey Clinical Trials Support Service Market Analysis

This report presents a strategic analysis of the Turkey Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Turkey Clinical Trials Support Service Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2023 | PRICE: $3999

Clinical Trials

UK Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis

This report presents a strategic analysis of the UK Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jan, 2023 | PRICE: $3999

subscribe to our newsletter
up